0% found this document useful (0 votes)
224 views2 pages

Lab MR #: 4844845: Molecular Diagnostics Test Name (Methodology) Result UOM

AmPath Central Reference Laboratory conducted a SARS-CoV-2 test on a nasopharyngeal and oropharyngeal swab sample from Mrs. CH Rajitha, a 30-year old female. The test result was negative, meaning SARS-CoV-2 RNA was not detected. The report notes that negative results do not rule out COVID-19 and that sensitivity depends on sample type and stage of infection. The sample was referred by Riya Diagnostic Centre and tested using real-time PCR technology.

Uploaded by

dileeppatra
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
224 views2 pages

Lab MR #: 4844845: Molecular Diagnostics Test Name (Methodology) Result UOM

AmPath Central Reference Laboratory conducted a SARS-CoV-2 test on a nasopharyngeal and oropharyngeal swab sample from Mrs. CH Rajitha, a 30-year old female. The test result was negative, meaning SARS-CoV-2 RNA was not detected. The report notes that negative results do not rule out COVID-19 and that sensitivity depends on sample type and stage of infection. The sample was referred by Riya Diagnostic Centre and tested using real-time PCR technology.

Uploaded by

dileeppatra
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 2

AmPath Central Reference Laboratory:

Door No. 1-100/1/CCH Nallagandla, Serilingampally


Hyderabad – 500019
040 6719 9977
www.ampath.com

PATIENT INFORMATION REFERRED BY SPECIMEN INFORMATION


Mrs. CH RAJITHA ..... SAMPLE TYPE :Nasopharyngeal &
RIYA DIAGNOSTIC CENTRE Oropharyngeal Swabs
AGE : 30Y ORDER REQ. NO :OREQ-LAB-21-2460830
GENDER : Female Lab MR #: 4844845 LAB ORDER. NO :2114187909
PRIORITY : Routine COLLECTED ON :22-May-2021 00:00
OP / IP / DG # : RECEIVED ON :22-May-2021 23:49
REPORT STATUS :Completed
RIYA DIAGNOSTIC CENTRE - MR#:
S113381863626

MOLECULAR DIAGNOSTICS
Test Name (Methodology) Result UOM

SARS-CoV-2 (COVID 19) Qualitative


(Real Time PCR) NEGATIVE
Test Observations:

Result Interpretation:
Result Remarks
Positive RNA specific to SARS-CoV-2 Detected
Negative RNA specific to SARS-CoV-2 Not Detected
Indeterminate This could be due to low viral load in the sample.
Repeat sample is recommended for confirmation

Note:

1. This report is pertaining to the sample provided.


2. Sensitivity of this test depends on the sample type submitted and stage of the infection.
3. Negative results do not rule out the possibility of COVID-19 virus infection. A number of factors could lead to a negative result, not limited to
Technical reasons inherent to the test, e.g. virus mutation or PCR inhibition
Viral load lower than limit of detection of the testing kit
Quality of the specimen.
4. Test conducted as per guidelines recommended by WHO and on the kits approved by ICMR/ CE-IVD/ USFDA.
5. The test result should be used in conjunction with clinical presentation.
6. Kindly consult referring Physician / Authorized Govt. hospital for appropriate follow-up.
7. Lower respiratory tract samples like BAL, ET aspirate are appropriate samples especially in severe and progressive lung disease.

Comments:

ICMR registration number for COVID-19 testing - AIPLH001.


COVID-19 is a new strain discovered in 2019 and belongs to large family of Coronaviruses and known to cause diseases such as Middle
East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV).
Reported illness have ranged from mild symptoms to severe illness and death for confirmed COVID-19 cases. Symptoms like fever, cough
and shortness of breath may appear 2-14 days after exposure.
The SARS-CoV-2 detection is a real-time PCR technology based test, for the qualitative detection and differentiation of lineage B-β Corona
virus (B-βCoV) and severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) specific RNA.
All test results are communicated to ICMR and to the respective local/state authorities as per the existing rules and regulations.

Dr. Haroon Hussain Syed


Checked by Mr. Chandrashekar V Consultant - Microbiology
Technologist 23-May-2021 07:20
-----End of Report-----

Generated On 23-May-2021 07:21:10 705.0048 This is an electronically authenticated laboratory report. Page 1 of 2

AmPath upholds rigorous standards for operational and clinical performance based on US hospital benchmarks. Test results have been furnished in adherence with
these standards and under the terms and conditions found on the reverse. For details, please email AmPath at customersupport@ampath.com.
AmPath Central Reference Laboratory:
Door No. 1-100/1/CCH Nallagandla, Serilingampally
Hyderabad – 500019
040 6719 9977
www.ampath.com

PATIENT INFORMATION REFERRED BY SPECIMEN INFORMATION


Mrs. CH RAJITHA ..... SAMPLE TYPE :Nasopharyngeal &
RIYA DIAGNOSTIC CENTRE Oropharyngeal Swabs
AGE : 30Y ORDER REQ. NO :OREQ-LAB-21-2460830
GENDER : Female Lab MR #: 4844845 LAB ORDER. NO :2114187909
PRIORITY : Routine COLLECTED ON :22-May-2021 00:00
OP / IP / DG # : RECEIVED ON :22-May-2021 23:49
REPORT STATUS :Completed
RIYA DIAGNOSTIC CENTRE - MR#:
S113381863626

MOLECULAR DIAGNOSTICS
Test Name (Methodology) Result UOM

Tests marked with (*) are not included in the scope of NABL accreditation

Generated On 23-May-2021 07:21:10 705.0048 This is an electronically authenticated laboratory report. Page 2 of 2

AmPath upholds rigorous standards for operational and clinical performance based on US hospital benchmarks. Test results have been furnished in adherence with
these standards and under the terms and conditions found on the reverse. For details, please email AmPath at customersupport@ampath.com.

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy